Intermittent androgen suppression

被引：16

作者：

Pether, M ^{[1
]}

Goldenberg, SL ^{[1
]}

机构：

[1] Univ British Columbia, Dept Surg, Div Urol, VGH,Prostate Ctr, Vancouver, BC V6T 1W5, Canada

来源：

关键词：

prostate cancer; androgens; intermittent therapy; outcome; survival;

D O I：

10.1111/j.1464-410X.2004.04597.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：258 / 261

页数：4

共 36 条

[21] Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy
July, LV
Akbari, M
Zellweger, T
Jones, EC
Goldenberg, SL
Gleave, ME
[J]. PROSTATE, 2002, 50 (03) : 179 - 188
[22] KLOTZ LH, 1986, CANCER, V58, P2546, DOI 10.1002/1097-0142(19861201)58:11<2546::AID-CNCR2820581131>3.0.CO
[23] 2-N
[24] MCDONNELL TJ, 1992, CANCER RES, V52, P6940
[25] MESSING EM, 1998, NEW ENGL J MED, V186, P63
[26] NOBLE RL, 1977, CANCER RES, V37, P82
[27] Pether Michael, 2003, Can J Urol, V10, P1809
[28] A 10-year clinical experience with intermittent hormonal therapy for prostate cancer
Prapotnich, D
Fizazi, K
Escudier, B
Mombet, A
Cathala, N
Vallancien, G
[J]. EUROPEAN UROLOGY, 2003, 43 (03) : 233 - 239
[29] RUSSO P, 1987, CANCER RES, V47, P5967
[30] Sato N, 1997, CANCER RES, V57, P1584